![]() |
|||
|
|
|
|
| UPDATE: August 2007 | MW: 246.39 | MF: C15H22N2O |
SYNONYMS:
|
|
| |
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
N/R
|
N/R
|
N/R
|
N/R
|
| |||
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intramuscular | rat
lowest published toxic dose: 6 mg/kg (11 day pregnant)
|
Reproductive: Effects on newborn: Behavioral
|
NTOTDY 8,61,1986
|
| |||
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intradermal | human
lowest published toxic dose: 5.63 mg/kg
|
Peripheral Nerve and Sensation: Local anesthetic | Behavioral: Analgesia
AANEAB 45,967,2001
|
intraperitoneal | mouse
lowest published lethal dose: 135 mg/kg
|
Behavioral: Somnolence (general depressed activity) | Behavioral: Tremor
TOIZAG 9,38,1962
|
intravenous | mouse
lethal dose (50 percent kill): 35 mg/kg
|
N/R
|
APTOA6 31,273,1972
|
intravenous | rat
lethal dose (50 percent kill): 30 mg/kg
|
N/R
|
ARVPAX 9,503,1969
|
intravenous | rabbit
lowest published lethal dose: 53 mg/kg
|
N/R
|
APTOA6 31,273,1972
|
oral | mouse
lethal dose (50 percent kill): >5 gm/kg
|
N/R
|
NIIRDN 6,845,1982
|
oral | mouse
lowest published toxic dose: 100 mg/kg
|
Gastrointestinal: Decreased motility or constipation
|
ETPAEK 57,59,2005
|
oral | rat
lethal dose (50 percent kill): >5 gm/kg
|
N/R
|
NIIRDN 6,845,1982
|
subcutaneous | mouse
lethal dose (50 percent kill): 270 mg/kg
|
N/R
|
AANEAB 9,1,1965
|
subcutaneous | rat
lethal dose (50 percent kill): 500 mg/kg
|
N/R
|
APTOA6 31,273,1972
|
| |||
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
TOXICOLOGY REVIEW
|
|
BNYMAM 52,222,1976
|
TOXICOLOGY REVIEW
|
|
AINCM* 5,132,2004
|
TOXICOLOGY REVIEW
|
|
BPCRA* 17,471,2003
|
| ||
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
N/R
|
N/R
|
N/R
|
| ||
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: X5788 |
Number of Industries 1; Total Number of Facilities 13; Number of Occupations 2; Total Number of Employees Exposed 545; Total Number of Female Employees Exposed 479 | |||
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
EPA TSCA Section 8(b) CHEMICAL INVENTORY
|
| ||
REFERENCES:
CODEN
|
|
REFERENCE
AANEAB
|
Acta Anaesthesiologica Scandinavica. (Munksgaard International Pub., POB 2148, DK-1016
Copenhagen K, Denmark) V.1- 1957-
|
AINCM*
|
Anaesthesia and Intensive Care Medicine (Abingdon: Medicine Pub. Co.) V.1- 2000-
|
APTOA6
|
Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher
information, see PHTOEH
|
ARVPAX
|
Annual Review of Pharmacology. (Palo Alto, CA) V.1-15, 1961-75. For publisher information,
see ARPTDI.
|
BNYMAM
|
Bulletin of the New York Academy of Medicine. (New York Academy of Medicine, 2 E. 103rd St.,
New York, NY 10029) Ser 2: V.1- 1925-
|
BPCRA*
|
Best Practice & Research Clinical Anaesthesiology(Elsevier Ltd.) V.13- 1999-
|
ETPAEK
|
Experimental and Toxicologic Pathology. (Gustav Fischer Verlag Jena, Postfach 100537, D-07705
Jena, Germany) V.44- 1992-
|
NIIRDN
|
Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan)
|
NTOTDY
|
Neurobehavioral Toxicology and Teratology. (Fayetteville, NY) V.3-8, 1981-86. For publisher
information, see NETEEC.
|
TOIZAG
|
Toho Igakkai Zasshi. Journal of Medical Society of Toho University. (Toho Daigaku Igakkai,
21-16, Omori-nishi, 5-chome, Ota-ku, Tokyo 143, Japan) V.1- 1954-
|
| |